A digital twin platform to combat respiratory diseases through high-value health intelligence
Ebenbuild has raised $2.7M in total funding. The most recent round was Grant. The last funding was announced in July 2025.
Ebenbuild's investors include HTGF (High-Tech Gruenderfonds), Bayern Kapital, EIC Accelerator.
Ebenbuild is headquartered in Munich, Germany.
A digital twin platform to combat respiratory diseases through high-value health intelligence
Ebenbuild is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ebenbuild — Funding & Investors." VCBacked, July 2, 2025, https://www.vcbacked.co/company/ebenbuild. Accessed August 14, 2026.
VCBacked. (2025). Ebenbuild — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/ebenbuild
{{cite web |title=Ebenbuild — Funding & Investors |url=https://www.vcbacked.co/company/ebenbuild |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated